[O10] Oral Session 10　Cross-sectional Program
【E】

[O10-3] Neoadjuvant vaccination with GBM6-AD, lysate of glioblastoma stem cell line, induces T-cell response in low-grade glioma

^○Hirokazu Ogino^1,2, Jennie W Taylor^2,3, Takahide Nejo², David Gibson², Payal B Watchmaker², Kaori Okada², Atsuro Saijo^1,2, Meghan Tadesco³, Jane Rabbitt², Michael R Olin⁴, Christopher L Moertel⁴, Andres M Salazar⁵, Yasuhiko Nishioka¹, Annette M Molinaro^2,7, Joanna J Phillips^2,6, Nicholas A Butowski², Jennifer L Clarke², Susan M Chang², Mitchel Berger², Hideho Okada² (1.Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, 2.Department of Neurological Surgery, University of California, San Francisco, 3.Department of Neurology, University of California, San Francisco, 4.Division of Pediatric Hematology/Oncology, University of Minnesota School of Medicine, 5.Oncovir Inc, 6.Division of Neuropathology, University of California, San Francisco, 7.Department of Epidemiology and Biostatistics, University of California, San Francisco)